Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Current assets    
Cash and cash equivalents $ 387,241 $ 370,776
Restricted cash 32,220 52,422
Accounts receivable, net of allowance for doubtful accounts of $5,860 (2012 - $7,899) 959,586 725,809
Rebates receivable 305,955 302,461
Other current assets 152,673 101,311
Total current assets 1,837,675 1,552,779
Property and equipment, net of accumulated depreciation of $103,858 (2012 - $64,048) 197,007 105,201
Goodwill 4,720,275 4,478,038
Other intangible assets, net of accumulated amortization of $363,546 (2012 - $178,188) 1,181,419 1,198,991
Other long-term assets 59,387 50,118
Total assets 7,995,763 7,385,127
Current liabilities    
Accounts payable 817,805 644,818
Accrued expenses and other current liabilities 254,100 254,811
Pharmacy benefit management rebates payable 356,265 302,065
Current portion - long-term debt 50,000 41,250
Total current liabilities 1,478,170 1,242,944
Deferred income taxes 301,341 344,232
Long-term debt 1,215,363 1,132,153
Other long-term liabilities 89,391 55,937
Total liabilities 3,084,265 2,775,266
Commitments and contingencies (Note 16)      
Shareholders’ equity    
Common shares: no par value, unlimited shares authorized; 206,305,070 shares issued and outstanding at December 31, 2013 (2012 - 205,399,102) 4,215,291 4,180,778
Additional paid-in capital 77,790 73,530
Retained earnings 617,161 354,991
Accumulated other comprehensive loss (1,752) (2,191)
Total shareholders' equity 4,908,490 4,607,108
Non-controlling interest 3,008 2,753
Total equity 4,911,498 4,609,861
Total liabilities and equity $ 7,995,763 $ 7,385,127